Diagnosis and Management of Non-Celiac Gluten Sensitivity

Confirming Celiac Disease Has Been Properly Excluded

The American Academy of Family Physicians recommends ensuring the patient was consuming adequate gluten (at least 10g daily for 6-8 weeks) when serologic testing was performed, as testing on a gluten-free or reduced-gluten diet yields false-negative results 3, 4
The American Gastroenterological Association suggests verifying total IgA level was measured alongside IgA tissue transglutaminase (tTG-IgA), since selective IgA deficiency occurs 10-15 times more frequently in celiac patients and causes falsely negative IgA-based testing 1, 5, 6
The American College of Gastroenterology recommends confirming upper endoscopy with duodenal biopsies was performed, not just serology alone—multiple biopsies (ideally 6 total: 1-2 from duodenal bulb and at least 4 from second part of duodenum) are required to properly exclude celiac disease 1, 3, 4

The American Gastroenterological Association states that HLA-DQ2 and HLA-DQ8 testing has a negative predictive value exceeding 99%—absence of both alleles essentially rules out celiac disease 1, 2, 7
The American Academy of Family Physicians suggests that HLA-DQ2 and HLA-DQ8 testing is particularly useful when celiac disease is strongly suspected despite negative serology, or when the patient has equivocal small-bowel histologic findings 1, 2, 5, 7

The American Academy of Family Physicians recommends documenting symptom improvement on a gluten-free diet for 6-8 weeks, and then performing a gluten rechallenge to confirm symptom recurrence with gluten reintroduction 1, 2
The American Gastroenterological Association states that symptoms alone or symptom response to a gluten-free diet cannot reliably differentiate celiac disease from NCGS, as there is substantial overlap in clinical presentations 1, 2

The American Academy of Family Physicians warns that never diagnosing NCGS without first properly excluding celiac disease with both serology and duodenal biopsies performed while the patient is consuming gluten 1, 2, 4
The American Gastroenterological Association advises against relying on negative serology alone to exclude celiac disease—seronegative celiac disease occurs, and biopsy remains the gold standard 6, 4

The American Academy of Family Physicians states that distinguishing celiac disease from NCGS has important clinical implications, including the risk of nutritional deficiencies and serious complications in celiac disease patients 1, 2
The American Gastroenterological Association notes that celiac disease requires lifelong strict gluten avoidance and ongoing monitoring, whereas the degree and duration of adherence to a gluten-free diet differs between conditions 2, 3